These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1208 related items for PubMed ID: 20492323

  • 1. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [Abstract] [Full Text] [Related]

  • 2. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E, Bergk A, Berg T.
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG, Mohammed R, Yuen MF, Kao JH.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [Abstract] [Full Text] [Related]

  • 4. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y, Sollano JD, Farrell GC.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [Abstract] [Full Text] [Related]

  • 5. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF.
    Semin Liver Dis; 2005 Apr; 25 Suppl 1():40-7. PubMed ID: 16103980
    [Abstract] [Full Text] [Related]

  • 6. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D, Han KH, Chan HL, Ueno Y, Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [Abstract] [Full Text] [Related]

  • 7. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, Levy M, Penman AG.
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [Abstract] [Full Text] [Related]

  • 8. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim BK, Han KH, Ahn SH.
    Oncology; 2011 May; 81 Suppl 1():41-9. PubMed ID: 22212935
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC.
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS.
    IARC Sci Publ; 1984 Aug; (63):243-61. PubMed ID: 6100273
    [Abstract] [Full Text] [Related]

  • 11. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
    Pár A.
    Orv Hetil; 2009 Jan 04; 150(1):19-26. PubMed ID: 19091671
    [Abstract] [Full Text] [Related]

  • 12. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D.
    Z Gastroenterol; 1997 Dec 04; 35(12):1059-67. PubMed ID: 9487638
    [Abstract] [Full Text] [Related]

  • 13. Prevention and treatment of hepatocellular carcinoma.
    Omata M, Yoshida H.
    Liver Transpl; 2004 Feb 04; 10(2 Suppl 1):S111-4. PubMed ID: 14762850
    [Abstract] [Full Text] [Related]

  • 14. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR, Marrero JA.
    Arch Med Res; 2007 Aug 04; 38(6):612-20. PubMed ID: 17613352
    [Abstract] [Full Text] [Related]

  • 15. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM, Lu SN.
    Oncology; 2011 Aug 04; 81 Suppl 1():36-40. PubMed ID: 22212934
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Aug 04; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 17. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.
    J Pathol; 2000 Oct 04; 192(2):207-15. PubMed ID: 11004697
    [Abstract] [Full Text] [Related]

  • 18. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA.
    Mutat Res; 2008 Oct 04; 659(1-2):176-84. PubMed ID: 18346933
    [Abstract] [Full Text] [Related]

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 04; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 20. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H, Lok AS.
    Antivir Ther; 2011 May 04; 16(6):787-95. PubMed ID: 21900710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.